TREA

90596751 - CRISPR BY DESIGN

Follow

Information

  • Trademark
  • 90596751
  • Serial Number
    90596751
  • Filing Date
    March 23, 2021
    4 years ago
  • Transaction Date
    January 29, 2025
    2 months ago
  • Status Date
    January 28, 2025
    2 months ago
  • Published for Opposition Date
    June 21, 2022
    2 years ago
  • Location Date
    October 23, 2024
    5 months ago
  • Status Code
    734
  • Employee Name
    VAGHANI, MAYUR
  • Attorney Docket Number
    333322.20000
    Attorney Name
    John Paul Oleksiuk
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CRISPR BY DESIGN
Case File Statements
  • GS0051: Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeuticsin the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics in the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders
  • GS0441: Molecular diagnostic testing, monitoring and reporting services for medical purposes and medical research purposes; Medical diagnostic testing services in the field of human disease and human medical conditions
  • DS0000: "CRISPR"
Case File Event Statements
  • 6/28/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/26/2021 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/27/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/28/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/28/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/28/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/26/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/26/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/26/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/19/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/1/2022 - 2 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/21/2022 - 2 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/21/2022 - 2 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/16/2022 - 2 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/8/2023 - 2 years ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/8/2023 - 2 years ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 2/8/2023 - 2 years ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 2/10/2023 - 2 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/10/2023 - a year ago
    21 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 8/10/2023 - a year ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/10/2023 - a year ago
    20 - SOU EXTENSION 2 FILED Type: EXT2
  • 2/8/2024 - a year ago
    24 - SOU EXTENSION 3 FILED Type: EXT3
  • 2/8/2024 - a year ago
    25 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 2/8/2024 - a year ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/9/2024 - a year ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/14/2024 - 7 months ago
    32 - SOU EXTENSION 4 FILED Type: EXT4
  • 8/19/2024 - 7 months ago
    35 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 10/23/2024 - 5 months ago
    29 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/12/2023 - a year ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/14/2024 - 7 months ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/19/2024 - 7 months ago
    28 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 11/22/2024 - 4 months ago
    31 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/16/2024 - 3 months ago
    36 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 12/16/2024 - 3 months ago
    33 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 11/18/2024 - 4 months ago
    30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/16/2024 - 3 months ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/22/2025 - 2 months ago
    39 - SOU EXTENSION 5 FILED Type: EXT5
  • 1/22/2025 - 2 months ago
    38 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/28/2025 - 2 months ago
    40 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 1/29/2025 - 2 months ago
    41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/16/2024 - 3 months ago
    37 - CORRECTED NOA E-MAILED Type: NOAC